Solventum earnings were $1.5B for the trailing 12 months ending Sep 30, 2025, with 110.8% growth year over year. The latest SOLV earnings report on Sep 30, 2025 announced Q3 2025 earnings of $1.3B, up 1,306.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SOLV reported annual earnings of $479.0M, with -64.4% growth.
SOLV past earnings growth
How has SOLV's earnings growth performed historically?
On SOLV's earnings call on Invalid Date, Solventum (NYSE: SOLV) reported Q3 2025 earnings per share (EPS) of $7.26, up 937.14% year over year. Total SOLV earnings for the quarter were $1.27 billion. In the same quarter last year, Solventum's earnings per share (EPS) was $0.70.
As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $1.52 billion, a 111.67% increase year over year.
What was SOLV's earnings growth in the past year?
As of Solventum's earnings date in Invalid Date, Solventum's earnings has grown 110.84% year over year. This is 80.38 percentage points higher than the US Health Information Services industry earnings growth rate of 30.46%. SOLV earnings in the past year totalled $1.52 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.